Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

774
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
774
Vaporization01:18

Vaporization

37.1K
The physical form of a substance changes by changing its temperature. For example, raising the temperature of a liquid causes the liquid to vaporize (convert into vapor). The process is called vaporization—a surface phenomenon. For vaporization to occur, kinetic energy must be greater than the intermolecular forces that keep molecules bonded. The amount of energy needed to vaporize a quantity of liquid at a given pressure and a constant temperature is called the heat of vaporization. When...
37.1K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

607
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
607
Inhaled Medications01:23

Inhaled Medications

641
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
641
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

2.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.0K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GME Momentum: Preserving Texas' Steady Progress in Building Residency Positions.

Texas medicine·2021
Same author

Accelerating RPM: COVID-19 Speeds Adoption of Remote Patient Monitoring.

Texas medicine·2021
Same author

Talk to Patients About: Vaccines and Cancer.

Texas medicine·2021
Same author

Keeping Children Safe: Prevention a More Prevalent Approach to Address Child Abuse, Neglect.

Texas medicine·2021
Same author

Routine Screen: Regular Testing Needed to End HIV Epidemic.

Texas medicine·2021
Same author

Another Great Match: Most Texas Medical Graduates Matched With Residency Positions.

Texas medicine·2021
Same journal

Commentary: This Is Not a Drill.

Texas medicine·2021
Same journal

Healthy Determination: Texas Physicians are Finding Better Ways to Address Their Patients' Social Determinants of Health.

Texas medicine·2021
Same journal

Going Local: Accountable Health Organizations Could Help Combat Social Disparities at the Local Level.

Texas medicine·2021
Same journal

Data Driven: Medicaid's Inspector General Focuses on Fraud Prevention, Not Just Prosecution.

Texas medicine·2021
Same journal

Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).

Texas medicine·2021
Same journal

Obstacles to Clear.

Texas medicine·2021
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.2K

Clearing the Haze: Texas Physicians Demystify Vaping.

Sean Price

    Texas Medicine
    |February 22, 2020
    PubMed
    Summary
    This summary is machine-generated.

    The increase in e-cigarette, or vaping, product use-associated lung injury (EVALI) cases presents a critical chance for medical professionals to advocate for stricter regulations and increased taxes on these harmful, largely unregulated products.

    More Related Videos

    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
    10:44

    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

    Published on: May 24, 2017

    11.9K
    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
    09:30

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

    Published on: January 18, 2018

    8.7K

    Related Experiment Videos

    Last Updated: Dec 28, 2025

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
    08:39

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

    Published on: August 25, 2018

    26.2K
    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
    10:44

    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

    Published on: May 24, 2017

    11.9K
    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
    09:30

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

    Published on: January 18, 2018

    8.7K

    Area of Science:

    • Public Health
    • Respiratory Medicine
    • Toxicology

    Background:

    • E-cigarette, or vaping, product use-associated lung injury (EVALI) has seen a significant increase in deaths and hospitalizations.
    • This public health crisis has shifted the discourse surrounding vaping.
    • The current regulatory landscape for vaping products in the U.S. and Texas is notably lax.

    Purpose of the Study:

    • To highlight the impact of EVALI on public health conversations.
    • To underscore the opportunity for physicians to influence policy regarding vaping products.
    • To advocate for enhanced regulatory measures and fiscal policies on vaping products.

    Main Methods:

    • Analysis of current trends in EVALI cases.
    • Review of existing regulations on vaping products.
    • Assessment of the health risks associated with vaping.

    Main Results:

    • The rise in EVALI necessitates a reevaluation of vaping product safety and regulation.
    • Physicians are uniquely positioned to lead advocacy efforts for policy change.
    • Vaping products are largely untested and pose significant health risks.

    Conclusions:

    • Urgent implementation of stricter regulations and higher taxes on vaping products is recommended.
    • Physicians should actively engage in policy discussions to protect public health from the harms of vaping.
    • Addressing the lightly regulated nature of vaping products is crucial for mitigating future health crises.